Month: May 2024

Enters into agreement to exchange $146 million of its outstanding 2026 Convertible Senior Notes for $100 million of 2029 Convertible...

Contacts Kopin Corporation Bill Maffucci, 508-870-5959 SVP of Business Development and Strategy bmaffucci@kopin.com Richard Sneider, 508-870-5959 Treasurer and Chief Financial...

  Highest Quarterly Gross Revenues in Company History Contacts For further information, contact: Wolf E. Regener, President and Chief Executive Officer...

Contacts Brad Delco Sr. Vice President – Finance (479) 820-2723 J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT) President of Intermodal...

PLYMOUTH MEETING, Pa., May 13, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines...

SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) has issued a press release with a...

Total Revenues Grew 10% Year Over Year Continued Net Income and EBITDA Improvements Contacts Contact Investor Relations: Gar Jackson (949)...

Contacts Investcorp Credit Management BDC, Inc. Investor Relations Email: ICMBinvestorrelations@investcorp.com Phone: 212-703-1154 Investcorp Credit Management BDC, Inc. (formerly CM Finance...

BOLINGBROOK, Ill., May 13, 2024 /PRNewswire/ -- Hyzon (NASDAQ: HYZN) (Hyzon or the Company), a U.S.-based manufacturer and global supplier...

GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined...

NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...

Fireside Chat to be Webcast Live Contacts Investors: Kern Kapoor | Hasbro, Inc. | hasbro_investor_relations@hasbro.com Media: Roberta Thomson | Hasbro,...

COLUMBIA, Md., May 13, 2024 /PRNewswire/ -- GSE Solutions ("GSE Systems, Inc." or "GSE") (Nasdaq: GVP), a leader in advanced engineering...

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- All Remote - GitLab Inc., (NASDAQ: GTLB), the most comprehensive AI-powered DevSecOps...

- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted...

Contacts LifeSci Advisors Mike Moyer, Managing Director mmoyer@lifesciadvisors.com Forte Biosciences, Inc. Paul Wagner, CEO investors@fortebiorx.com Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:...

TOKYO, May 13, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating...

Company to Host Conference Call at 5:00 pm ET Monday May 13, 2024 PORTLAND, Oregon, May 13, 2024 /PRNewswire/ --...

MIDLAND, Texas, May 13, 2024 /PRNewswire/ -- Dawson Geophysical Company (NASDAQ: DWSN) (the "Company") today reported unaudited financial results for...

JACKSONVILLE, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), a provider...

HOUSTON, May 13, 2024 /PRNewswire/ -- Drilling Tools International Corp., (NASDAQ: DTI) ("DTI" or the "Company"), a global oilfield services...

-         FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis -         Webcast of Earnings...

New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024Total...

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition...

Contacts Cepton, Inc. Investors: InvestorRelations@cepton.com Media: Faithy Li, media@cepton.com Cepton, Inc. (“Cepton”) (Nasdaq ticker: CPTN), a Silicon Valley innovator and...

BOSTON and LONDON, May 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims...

Contacts Investor Contact Shane Xie investors@confluent.io Media Contact Justin Dorff pr@confluent.io Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today...

Contacts Cross Country Healthcare, Inc. Josh Vogel, Vice President, Investor Relations 561-237-8310 jvogel@crosscountry.com Cross Country Healthcare, Inc. (the “Company”) (Nasdaq:...

STAMFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new...

–Phase 3, HOPE-3 Trial (Cohort A) of CAP-1002 in Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in...

Last patient enrolled in CARPO, Phase 2b trial of Auxora™ in acute pancreatitis (AP); topline data expected in 2Q 2024...

Increased Adoption of Dental Lasers and Improved Cost Structure Position Company for Sustained Long Term Growth and Success LAKE FOREST,...

FORT LAUDERDALE, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of...

FORT LAUDERDALE, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of...

SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data...

DOYLESTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage...

MAUMEE, Ohio, May 13, 2024 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces that it will present at the BMO Capital...

SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the...

MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position...